A review of analytical methods for the determination of 5-fluorouracil in biological matrices.
5-Fluorouracil (5-FU) is a cytostatic agent that has been widely used in the treatment of various solid tumours for more than 20 years, and is still considered to be among the most active antineoplastic agents in advanced colorectal cancer and malignancies of the head and neck. A large number of non-chromatographic and chromatographic methods for the quantitation of 5-FU, related prodrugs and their metabolites in biological matrices have been developed in the last 30 years to support preclinical and clinical studies. However, 5-FU monitoring has not been widely used, at least not in the USA, and certainly not outside the clinical research setting, given the absence of simple, fast and inexpensive testing methods for 5-FU monitoring. Recent developments with testing based on liquid chromatography-tandem mass spectrometry and a nanoparticle antibody-based immunoassay may facilitate routine monitoring of 5-FU in daily clinical practice. In this review the advantages and disadvantages of the bioanalytical methods developed and used for 5-FU, its metabolites and related prodrugs are discussed.
Breda
Massimo
M
Accelera S.r.l., Viale Pasteur 10, 20014 Nerviano, Italy. massimo.breda@accelera.org
Barattè
Simona
S
D000964:Antimetabolites, Antineoplastic / Q000032:analysis* / Q000378:metabolism / Q000493:pharmacokinetics; D002623:Chemistry Techniques, Analytical / Q000191:economics / Q000379:methods*; D016903:Drug Monitoring / Q000191:economics / Q000379:methods*; D005472:Fluorouracil / Q000032:analysis* / Q000378:metabolism / Q000493:pharmacokinetics; D006801:Humans; D011355:Prodrugs / Q000032:analysis / Q000378:metabolism / Q000493:pharmacokinetics; D005641:Tegafur / Q000032:analysis / Q000378:metabolism / Q000493:pharmacokinetics
D000964:Antimetabolites, Antineoplastic; D011355:Prodrugs; D005641:Tegafur; D005472:Fluorouracil